you are here: HomeNewsBusiness

Buy Advanced Enzyme Technologies; target of Rs 480: ICICI Direct

ICICI Direct is bullish on Advanced Enzyme Technologies has recommended buy rating on the stock with a target price of Rs 480 in its research report dated February 16, 2021.

February 17, 2021 / 04:32 PM IST
  • bselive
  • nselive
Todays L/H

ICICI Direct's research report on Advanced Enzyme Technologies

Q3 revenues grew 23.0% YoY to Rs 137.7 crore on the back of 34.9% YoY growth in human healthcare (HC) segment to Rs 108.9 crore. Animal HC saw a decline of 29.5% YoY to Rs 10.5 crore whereas industrial processing segment grew 12.3% YoY to Rs 18.3 crore. EBITDA margins expanded 97 bps YoY to 48.2% with lower employee & other expenditure being partly offset by lower gross margins. Hence, EBITDA grew 25.6% YoY to Rs 66.4 crore. PAT grew 28.2% YoY to Rs 43.1 crore in-line with operational performance.


We maintain BUY with a revised target price of Rs 480 (earlier Rs 425) based on 25x FY23E EPS of Rs 19.2.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Feb 17, 2021 04:32 pm

stay updated

Get Daily News on your Browser